219 related articles for article (PubMed ID: 19373194)
1. [Structure and function of complement protein C1q and its role in the development of autoimmune diseases].
Smykał-Jankowiak K; Niemir ZI
Postepy Hig Med Dosw (Online); 2009 Apr; 63():134-41. PubMed ID: 19373194
[TBL] [Abstract][Full Text] [Related]
2. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains.
Kishore U; Gupta SK; Perdikoulis MV; Kojouharova MS; Urban BC; Reid KB
J Immunol; 2003 Jul; 171(2):812-20. PubMed ID: 12847249
[TBL] [Abstract][Full Text] [Related]
3. C1q and systemic lupus erythematosus.
Walport MJ; Davies KA; Botto M
Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
5. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
Botto M
Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
[TBL] [Abstract][Full Text] [Related]
6. Classical pathway deficiencies - A short analytical review.
Truedsson L
Mol Immunol; 2015 Nov; 68(1):14-9. PubMed ID: 26038300
[TBL] [Abstract][Full Text] [Related]
7. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.
van Schaarenburg RA; Daha NA; Schonkeren JJ; Nivine Levarht EW; van Gijlswijk-Janssen DJ; Kurreeman FA; Roos A; van Kooten C; Koelman CA; Ernst-Kruis MR; Toes RE; Huizinga TW; Lankester AC; Trouw LA
Immunobiology; 2015 Mar; 220(3):422-7. PubMed ID: 25454803
[TBL] [Abstract][Full Text] [Related]
9. C1q, autoimmunity and apoptosis.
Botto M; Walport MJ
Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
[TBL] [Abstract][Full Text] [Related]
10. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance.
Roumenina LT; Sène D; Radanova M; Blouin J; Halbwachs-Mecarelli L; Dragon-Durey MA; Fridman WH; Fremeaux-Bacchi V
J Immunol; 2011 Oct; 187(8):4369-73. PubMed ID: 21930969
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
[TBL] [Abstract][Full Text] [Related]
12. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
13. Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies.
Kojouharova MS; Tsacheva IG; Tchorbadjieva MI; Reid KB; Kishore U
Biochim Biophys Acta; 2003 Nov; 1652(1):64-74. PubMed ID: 14580997
[TBL] [Abstract][Full Text] [Related]
14. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
15. C1q: a multifunctional ligand for a new immunoadsorption treatment.
Hiepe F; Pfüller B; Wolbart K; Bruns A; Leinenbach HP; Hepper M; Schössler W; Otto V
Ther Apher; 1999 Aug; 3(3):246-51. PubMed ID: 10427623
[TBL] [Abstract][Full Text] [Related]
16. Hereditary C1q deficiency and systemic lupus erythematosus.
Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
18. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
Wisnieski JJ; Jones SM
J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
[TBL] [Abstract][Full Text] [Related]
19. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
20. Relevance of anti-C1q autoantibodies to lupus nephritis.
Tsirogianni A; Pipi E; Soufleros K
Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
